A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

NCT06747936 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: AD-2281
DRUG: AD-2282
DRUG: Placebo of AD-2282

Sponsor

Addpharma Inc.